(PubMed) Kalmijn S, van Boxtel MP, Ocke M, Verschuren WM, Kromhout D, Launer LJ
Seeking to amend the federal Food, Drug, and Cosmetic Act (FDCA), the bills sponsors frame the proposed legislation as essential to protect patients from untested, unapproved, and potentially dangerous mass compounded drugs. The bill was immediately referred to the House Committee on Energy and Commerce
They can help lower costs, but consistency matters, so any switch in pharmacy or medication should be discussed with a healthcare provider
This process involves a personalized approach to dosing, regular assessment of clinical parameters, and patient education
Tsampasian V, Baral R, Chattopadhyay R et al (2021) The role of SGLT2 inhibitors in heart failure: a systematic review and meta-analysis
Diabetes 70 , 13471356 (2021)